Antoine Yver Centessa Pharmaceuticals PLC (CNTA) insider trading activity

Antoine Yver is EVP & Chairman of Development of Centessa Pharmaceuticals plc. Currently has a direct ownership of 783,066 shares of CNTA, which is worth approximately $13.2 Million. The most recent transaction as insider was on Jun 01, 2023, when has been sold 6,500 shares (Ordinary Shares) at a price of $4.45 per share, resulting in proceeds of $28,925. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 783K

0% 3M change

0% 12M change

Total Value Held $13.2 Million

ANTOINE YVER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 01 2023	SELL Open market or private sale	$28,925 $4.45 p/Share	6,500 Reduced 0.82%	783,066 Ordinary Shares
May 01 2023	SELL Open market or private sale	$30,056 $4.42 p/Share	6,800 Reduced 0.85%	789,566 Ordinary Shares
Apr 03 2023	SELL Open market or private sale	$24,723 $3.69 p/Share	6,700 Reduced 0.83%	796,366 Ordinary Shares
Mar 31 2023	SELL Payment of exercise price or tax liability	$14,098 $3.9 p/Share	3,615 Reduced 0.45%	803,066 Ordinary Shares
Mar 01 2023	SELL Open market or private sale	$23,940 $3.42 p/Share	7,000 Reduced 0.86%	806,681 Ordinary Shares
Feb 01 2023	SELL Open market or private sale	$29,183 $3.79 p/Share	7,700 Reduced 0.94%	813,681 Ordinary Shares
Feb 01 2023	BUY Grant, award, or other acquisition	-	77,200 Added 8.59%	821,381 Ordinary Shares
Jan 04 2023	SELL Open market or private sale	$22,164 $3.18 p/Share	6,970 Reduced 0.92%	751,913 Ordinary Shares
Dec 31 2022	SELL Payment of exercise price or tax liability	$7,030 $3.1 p/Share	2,268 Reduced 0.3%	758,883 Ordinary Shares
Dec 01 2022	SELL Open market or private sale	$36,754 $3.91 p/Share	9,400 Reduced 1.22%	761,151 Ordinary Shares
Nov 01 2022	SELL Open market or private sale	$39,091 $4.03 p/Share	9,700 Reduced 1.25%	765,059 Ordinary Shares
Oct 03 2022	SELL Open market or private sale	$49,094 $3.92 p/Share	12,524 Reduced 1.59%	774,759 Ordinary Shares
Sep 30 2022	SELL Payment of exercise price or tax liability	$32,861 $4.25 p/Share	7,732 Reduced 0.98%	782,019 Ordinary Shares
Sep 30 2022	SELL Open market or private sale	$10,045 $4.07 p/Share	2,468 Reduced 0.31%	787,283 Ordinary Shares
Sep 01 2022	SELL Open market or private sale	$45,965 $4.41 p/Share	10,423 Reduced 1.3%	789,751 Ordinary Shares
Aug 01 2022	SELL Open market or private sale	$46,382 $4.45 p/Share	10,423 Reduced 1.29%	800,174 Ordinary Shares
Jul 18 2022	SELL Open market or private sale	$97,400 $4.87 p/Share	20,000 Reduced 2.41%	810,597 Ordinary Shares
Jul 01 2022	SELL Open market or private sale	$45,773 $5.03 p/Share	9,100 Reduced 1.23%	730,597 Ordinary Shares
Jul 01 2022	BUY Grant, award, or other acquisition	-	100,000 Added 10.75%	830,597 Ordinary Shares
Jun 17 2022	SELL Open market or private sale	$43,056 $4.68 p/Share	9,200 Reduced 1.23%	739,697 Ordinary Shares
May 18 2022	SELL Open market or private sale	$330,368 $5.1 p/Share	64,778 Reduced 7.96%	748,897 Ordinary Shares
May 17 2022	SELL Open market or private sale	$109,603 $5.42 p/Share	20,222 Reduced 2.42%	813,675 Ordinary Shares
May 27 2021	BUY Grant, award, or other acquisition	-	833,897 Added 50.0%	833,897 Ordinary Shares

Antoine Yver

EVP & Chairman of Development

Cheshire, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Value

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Centessa Pharmaceuticals plc

Track Activities on CNTA

Account